Navigating the Sotatercept landscape: A meta‐analysis of clinical outcomes
Open Access
- 11 October 2023
- journal article
- review article
- Published by Wiley in Clinical Cardiology
- Vol. 47 (1)
Abstract
Pulmonary arterial hypertension (PAH) is a widespread condition that affects around 1% of the global population, with a higher prevalence among older individuals. The approach to managing PAH has undergone significant changes, requiring extensive treatment strategies. Sotatercept, an FDA‐approved medication, has recently attracted attention for its potential role in PAH therapy. However, information on its safety and effectiveness is scarce. In this study, we performed a meta‐analysis of existing randomized clinical trials to assess the impact of Sotatercept on PAH patients. Our findings revealed that those treated with Sotatercept showed greater improvement in pulmonary vascular resistance and World Health Organization functional class compared with placebo recipients. The occurrence of adverse events was similar between both groups. Importantly, the Sotatercept group displayed a considerably higher number of cases with an increase in hemoglobin levels. Considering that about 33% of PAH patients experience anemia and both anemia and polycythemia can adversely affect disease prognosis, additional research is necessary to establish the potential advantages and disadvantages of Sotatercept as a treatment choice, specifically regarding its erythropoietic properties.Keywords
This publication has 7 references indexed in Scilit:
- Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial HypertensionNew England Journal of Medicine, 2023
- Sotatercept analog suppresses inflammation to reverse experimental pulmonary arterial hypertensionScientific Reports, 2022
- Sotatercept for the Treatment of Pulmonary Arterial HypertensionNew England Journal of Medicine, 2021
- Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort studyThe Lancet Respiratory Medicine, 2020
- Anaemia, iron homeostasis and pulmonary hypertension: a reviewInternal and Emergency Medicine, 2020
- Blood Viscosity and its Relevance to the Diagnosis and Management of Pulmonary HypertensionJACC, 2019
- Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017)Circulation Journal, 2019